Follow
Dávid Tornai
Dávid Tornai
Verified email at med.unideb.hu - Homepage
Title
Cited by
Cited by
Year
MicroRNA 122, regulated by GRLH2, protects livers of mice and patients from ethanol-induced liver disease
A Satishchandran, A Ambade, S Rao, YC Hsueh, A Iracheta-Vellve, ...
Gastroenterology 154 (1), 238-252. e7, 2018
1432018
Biomarkers of macrophage activation and immune danger signals predict clinical outcomes in alcoholic hepatitis
B Saha, D Tornai, K Kodys, A Adejumo, P Lowe, C McClain, M Mitchell, ...
Hepatology 70 (4), 1134-1149, 2019
722019
IL‐1 receptor antagonist plus pentoxifylline and zinc for severe alcohol‐associated hepatitis
G Szabo, M Mitchell, CJ McClain, S Dasarathy, B Barton, AJ McCullough, ...
Hepatology 76 (4), 1058-1068, 2022
692022
Neutrophil extracellular traps contribute to liver damage and increase defective low-density neutrophils in alcohol-associated hepatitis
Y Cho, TN Bukong, D Tornai, M Babuta, IS Vlachos, E Kanata, D Catalano, ...
Journal of Hepatology 78 (1), 28-44, 2023
592023
Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis
T Tornai, E Palyu, Z Vitalis, I Tornai, D Tornai, P Antal-Szalmas, ...
World journal of gastroenterology 23 (29), 5412, 2017
482017
Deleterious effect of proton pump inhibitors on the disease course of cirrhosis
T Janka, T Tornai, B Borbély, D Tornai, I Altorjay, M Papp, Z Vitális
European journal of gastroenterology & hepatology 32 (2), 257-264, 2020
402020
Presepsin teardown-pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis
M Papp, T Tornai, Z Vitalis, I Tornai, D Tornai, T Dinya, A Sumegi, ...
World Journal of Gastroenterology 22 (41), 9172, 2016
352016
Macrophage activation marker, soluble CD 163, is an independent predictor of short‐term mortality in patients with cirrhosis and bacterial infection
T Tornai, Z Vitalis, N Sipeki, T Dinya, D Tornai, P Antal‐Szalmas, ...
Liver International 36 (11), 1628-1638, 2016
352016
Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis
T Tornai, D Tornai, N Sipeki, I Tornai, R Alsulaimani, K Fechner, ...
Scientific reports 8 (1), 399, 2018
292018
Lectin‐complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections
I Foldi, T Tornai, D Tornai, N Sipeki, Z Vitalis, I Tornai, T Dinya, ...
Liver International 37 (7), 1023-1031, 2017
282017
Inhibition of triggering receptor expressed on myeloid cells 1 ameliorates inflammation and macrophage and neutrophil activation in alcoholic liver disease in mice
D Tornai, I Furi, ZT Shen, AB Sigalov, S Coban, G Szabo
Hepatology Communications 3 (1), 99-115, 2019
272019
Emerging medical therapies for severe alcoholic hepatitis
D Tornai, G Szabo
Clinical and Molecular Hepatology 26 (4), 686, 2020
242020
Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value
S Sciascia, N Bizzaro, PL Meroni, B Dimitrios, MO Borghi, X Bossuyt, ...
Autoimmunity Reviews 22 (7), 103356, 2023
222023
Phenotypic polymorphism of haptoglobin: a novel risk factor for the development of infection in liver cirrhosis
Z Vitalis, I Altorjay, I Tornai, K Palatka, S Kacska, E Palyu, D Tornai, ...
Human immunology 72 (4), 348-354, 2011
192011
Inhibition of the inflammasome signaling cascade reduces alcohol consumption in female but not male mice
PP Lowe, Y Cho, D Tornai, S Coban, D Catalano, G Szabo
Alcoholism: Clinical and Experimental Research 44 (2), 567-578, 2020
182020
Serological biomarkers for management of primary sclerosing cholangitis
D Tornai, PL Ven, PL Lakatos, M Papp
World Journal of Gastroenterology 28 (21), 2291-2301, 2022
152022
Functional polymorphisms of innate immunity receptors are not risk factors for the non‐SBP type bacterial infections in cirrhosis
T Dinya, T Tornai, Z Vitalis, I Tornai, B Balogh, D Tornai, P Antal‐Szalmas, ...
Liver International 38 (7), 1242-1252, 2018
122018
Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study
D Tornai, P Antal-Szalmas, T Tornai, M Papp, I Tornai, N Sipeki, T Janka, ...
BMC Gastroenterology 21 (1), 2021
102021
Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality
D Tornai, Z Vitalis, A Jonas, T Janka, I Foldi, T Tornai, N Sipeki, A Csillag, ...
Clinics and Research in Hepatology and Gastroenterology 45 (5), 101579, 2021
82021
serologic antibodies in primary sclerosing cholangitis – a tell‐tale sign of compromised gut‐liver immunity?
D Tornai, M Papp
Alimentary Pharmacology & Therapeutics 53 (2), 350-351, 2020
82020
The system can't perform the operation now. Try again later.
Articles 1–20